Lin28 and let-7 in the Metabolic Physiology of Aging

Trends in Endocrinology and Metabolism

Volumn 27, Issue 3, 2016, Pages 132-141

  Jun Hao, Elwin Tan ^a   Gupta, Renuka Ravi ^a   Shyh Chang, Ng ^a  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Cancer; Cardiomyopathy; Diabetes; Let 7; Lin28; Metabolism

Indexed keywords

INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; RNA; LIN-28 PROTEIN, HUMAN; MICRORNA; MIRNLET7 MICRORNA, HUMAN; RNA BINDING PROTEIN;

AGING; CARCINOGENESIS; CARDIAC REGENERATION; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL GROWTH; CELL METABOLISM; EPIGENETICS; GENE; GENETIC ASSOCIATION; GROWTH; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; LET 7 GENE; LIN28 GENE; LONGEVITY; METABOLIC DISORDER; METABOLISM; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REGENERATION; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; ANIMAL; BIOLOGICAL MODEL; CARDIAC MUSCLE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STEM CELL;

AGING; ANIMALS; CARCINOGENESIS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISLETS OF LANGERHANS; LONGEVITY; MICRORNAS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; MYOCARDIUM; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84958117331     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.12.006     Document Type: Review

References (83)

1. Horvitz H.R., Sulston J.E. Isolation and genetic characterization of cell-lineage mutants of the nematode Caenorhabditis elegans. Genetics 1980, 96:435-454.
2. Ambros V., Horvitz H.R. Heterochronic mutants of the nematode Caenorhabditis elegans. Science 1984, 226:409-416.
3. Moss E.G., et al. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 1997, 88:637-646.
4. Reinhart B.J., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
5. Pasquinelli A.E., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
6. Abbott A.L., et al. The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev. Cell 2005, 9:403-414.
7. Moss E.G., Tang L. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev. Biol. 2003, 258:432-442.
8. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
9. Thomson J.M., et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006, 20:2202-2207.
10. Viswanathan S.R., et al. Selective blockade of microRNA processing by Lin28. Science 2008, 320:97-100.
11. Rybak A., et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat. Cell Biol. 2008, 10:987-993.
12. Heo I., et al. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol. Cell 2008, 32:276-284.
13. Newman M.A., et al. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 2008, 14:1539-1549.
14. Lehrbach N.J., et al. LIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing in Caenorhabditis elegans. Nat. Struct. Mol. Biol. 2009, 16:1016-1020.
15. Van Wynsberghe P.M. LIN-28 co-transcriptionally binds primary let-7 to regulate miRNA maturation in Caenorhabditis elegans. Nat. Struct. Mol. Biol. 2011, 18:302-308.
16. Shyh-Chang N., Daley G.Q. Lin28: Primal regulator of growth and metabolism in stem cells. Cell Stem Cell 2013, 12:395-406.
17. Dubinsky A.N., et al. Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy. Cell Metab. 2014, 20:626-638.
18. Polesskaya A., et al. Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev. 2007, 21:1125-1138.
19. Peng S., et al. Genome-wide studies reveal that Lin28 enhances the translation of genes important for growth and survival of human embryonic stem cells. Stem Cells 2011, 29:496-504.
20. Zhu H., et al. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011, 147:81-94.
21. Bhuiyan M.I., et al. Expression of exogenous LIN28 contributes to proliferation and survival of mouse primary cortical neurons in vitro. Neuroscience 2013, 17:448-458.
22. Yang M., et al. Lin28 promotes the proliferative capacity of neural progenitor cells in brain development. Development 2015, 142:1616-1627.
23. Zhu H., et al. Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies. Nat. Genet. 2010, 42:626-630.
24. Duvel K., et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 2010, 39:171-183.
25. Schieke S.M., et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem. 2006, 281:27643-27652.
26. Cunningham J.T. mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex. Nature 2007, 450:736-740.
27. Ramanathan A., Schreiber S.L. Direct control of mitochondrial function by mTOR. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:22229-22232.
28. Le M.T., et al. Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genet. 2011, 7:e1002242.
29. Vander Heiden M.G., et al. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
30. Janiszewska M.S., et al. Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev. 2012, 26:1926-1944.
31. Shyh-Chang N., et al. Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell 2013, 155:778-792.
32. Johnson S.M., et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
33. Benhamed M., et al. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat. Cell Biol. 2012, 14:266-275.
34. Viswanathan S.R., et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 2009, 41:843-848.
35. Molenaar J.J., et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat. Genet. 2012, 44:1199-1206.
36. Beachy S.H., et al. Enforced expression of Lin28b leads to impaired T-cell development, release of infl ligatureammatory cytokines, and peripheral T-cell lymphoma. Blood 2012, 120:1048-1059.
37. Urbach A., et al. Lin28 sustains early renal progenitors and induces Wilms tumor. Genes Dev. 2014, 28:971-982.
38. Nguyen L.H., et al. Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell 2014, 26:248-261.
39. King C.E., et al. LIN28B promotes colon cancer progression and metastasis. Cancer Res. 2011, 71:4260-4268.
40. Tu H.C., et al. LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans. Genes Dev. 2015, 29:1074-1086.
41. Diskin S.J., et al. Common variation at 6q16 within HACE1 and LIN28B infl ligatureuences susceptibility to neuroblastoma. Nat. Genet. 2012, 44:1126-1130.
42. Ma, et al. Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1. Nat. Commun. 2014, 5:5212.
43. Shinoda G., et al. Fetal deficiency of Lin28 programs life-long aberrations in growth and glucose metabolism. Stem Cells 2013, 31:1563-1573.
44. Frost R.J., Olson E.N. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:21075-21080.
45. Lettre G., et al. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat. Genet. 2008, 40:584-591.
46. Widén E., et al. Distinct variants at LIN28B influence growth in height from birth to adulthood. Am. J. Hum. Genet. 2010, 86:773-782.
47. Voight B.F., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 42:579-589.
48. Zhang J., et al. The polymorphism in the let-7 targeted region of the Lin28 gene is associated with increased risk of type 2 diabetes mellitus. Mol. Cell. Endocrinol. 2013, 375:53-57.
49. Drummond M.J., et al. Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol. Genomics 2011, 43:595-603.
50. Zhou X., et al. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995, 376:771-774.
51. Battista S., et al. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res. 1999, 59:4793-4797.
52. Hansen T.V.O., et al. Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol. Cell. Biol. 2004, 24:4448-4464.
53. Brants J.R., et al. Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2. FEBS Lett. 2004, 569:277-283.
54. Cleynen I., et al. HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB. Mol. Cancer Res. 2007, 5:363-372.
55. Dai N., et al. IGF2BP2/IMP2-Deficient mice resist obesity through enhanced translation of Ucp1 mRNA and Other mRNAs encoding mitochondrial proteins. Cell Metab. 2015, 21:609-621.
56. Foti D., et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat. Med. 2005, 11:765-773.
57. Chiefari E., et al. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat. Comm. 2010, 1:40.
58. Li Z., et al. An HMGA2-IGF2BP2 axis regulates myoblast proliferation and myogenesis. Dev. Cell 2012, 23:1176-1188.
59. Hales C.N., Barker D.J.P. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992, 35:595-601.
60. Hanson M.A., Gluckman P.D. Early developmental conditioning of later health and disease: physiology or pathophysiology?. Physiol. Rev. 2014, 94:1027-1076.
61. Kallen A.N., et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 2013, 52:101-112.
62. Gao Y., et al. The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res. 2014, 42:13799-13811.
63. Katayama M., et al. miRNA let-7 expression is regulated by glucose and TNF-alpha by a remote upstream promoter. Biochem. J. 2015, 472:147-156.
64. Monnier P., et al. H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. Proc. Natl. Acad. Sci. U.S.A. 2014, 110:20693-20698.
65. Wang J., et al. MicroRNA-125b/Lin28 pathway contributes to the mesoendodermal fate decision of embryonic stem cells. Stem Cells Dev. 2012, 21:1524-1536.
66. Kuppusamy K.T., et al. Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E2785-E2794.
67. Bao M.H., et al. Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int. J. Mol. Sci. 2013, 14:23086-23102.
68. Gray C., et al. Let-7 miRNA profiles are associated with the reversal of left ventricular hypertrophy and hypertension in adult male offspring from mothers undernourished during pregnancy after preweaning growth hormone treatment. Endocrinology 2014, 155:4808-4817.
69. Tolonen A.M., et al. Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice. Pharmacol. Res. Perspect. 2014, 2:e00056.
70. Zhang M., et al. Lin28a protects against cardiac ischaemia/reperfusion injury in diabetic mice through the insulin-PI3K-mTOR pathway. J. Cell. Mol. Med. 2015, 19:1174-1182.
71. Zhang M., et al. Lin28a protects against hypoxia/reoxygenation induced cardiomyocytes apoptosis by alleviating mitochondrial dysfunction under high glucose/high fat conditions. PLoS ONE 2014, 9:e110580.
72. Monzen K., et al. A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat. Cell Biol. 2008, 10:567-574.
73. Aguirre A., et al. In vivo activation of a conserved microRNA program induces mammalian heart regeneration. Cell Stem Cell 2014, 15:589-604.
74. Bartke A. Healthy aging: is smaller better - a mini-review. Gerontology 2012, 58:337-343.
75. Barbieri M., et al. Glucose regulation and oxidative stress in healthy centenarians. Exp. Gerontol. 2003, 38:137-143.
76. Rudolph K.L., et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96:701-712.
77. Tyner S.D., et al. P53 mutant mice that display early ageing-associated phenotypes. Nature 2002, 415:45-53.
78. Wu L., et al. Precise let-7 expression levels balance organ regeneration against tumor suppression. Elife 2015, 4:09431.
79. Yilmaz O.H., et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475-482.
80. Shyh-Chang N., et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 2013, 339:222-226.
81. Khaw S.L., et al. Oocyte factors suppress mitochondrial polynucleotide phosphorylase to remodel the metabolome and enhance reprogramming. Cell Rep. 2015, 12:1080-1088.
82. Shyh-Chang N., Daley G.Q. Metabolic switches linked to pluripotency and embryonic stem cell differentiation. Cell Metab. 2015, 21:349-350.
83. Min-Wen J.C., et al. Stem cell mitochondria during aging. Semin. Cell Dev. Biol. 2016, 10.1016/j.semcdb.2016.02.005.